Table 4.
Top pathways and their associated p-values. P-values are presented by using Fisher’s method, and then corrected for multiple comparisons using false discovery rate (FDR) and Bonferroni corrections.
| Pathway Name | Pathway ID | p-value | p-value (FDR) | p-value (Bonferroni) |
|---|---|---|---|---|
|
| ||||
| African trypanosomiasis | 5143 | 3.88426E-06 | 0.00058652 | 0.000586524 |
| Malaria | 5144 | 3.89219E-05 | 0.00293860 | 0.005877213 |
| Cytokine-cytokine receptor interaction | 4060 | 0.000153046 | 0.00770329 | 0.023109898 |
| Adrenergic signaling in cardiomyocytes | 4261 | 0.002860454 | 0.08140411 | 0.43192861 |
| PI3K-Akt signaling pathway | 4151 | 0.002980936 | 0.08140411 | 0.450121393 |
| Cardiac muscle contraction | 4260 | 0.003234601 | 0.08140411 | 0.488424716 |
| Ras signaling pathway | 4014 | 0.004489364 | 0.08219767 | 0.677894016 |
| Gastric acid secretion | 4971 | 0.004643523 | 0.08219767 | 0.701172005 |
| Ether lipid metabolism | 565 | 0.004899199 | 0.08219767 | 0.739779028 |
The p-value corresponding to the pathway was computed using only overrepresentation analysis. Bonferroni reduces the false discovery rate by imposing a stringent threshold on each comparison adjusted for the total number of comparisons.